Tumour targeting with radiometals for diagnosis and therapy

CF Ramogida, C Orvig - Chemical Communications, 2013 - pubs.rsc.org
Use of radiometals in nuclear oncology is a rapidly growing field and encompasses a broad
spectrum of radiotracers for imaging via PET (positron emission tomography) or SPECT …
被引用次数：288 相关文章

Tumour targeting with radiometals for diagnosis and therapy

CF Ramogida, C Orvig - Chemical communications …, 2013 - pubmed.ncbi.nlm.nih.gov
Use of radiometals in nuclear oncology is a rapidly growing field and encompasses a broad
spectrum of radiotracers for imaging via PET (positron emission tomography) or SPECT …

Tumour targeting with radiometals for diagnosis and therapy.

CF Ramogida, C Orvig - Chemical Communications (Cambridge …, 2013 - europepmc.org
Use of radiometals in nuclear oncology is a rapidly growing field and encompasses a broad
spectrum of radiotracers for imaging via PET (positron emission tomography) or SPECT …
[PDF] researchgate.net

[PDF][PDF] Tumour targeting with radiometals for diagnosis and therapy

CF Ramogidaab, C Orvig - Chem. Commun, 2013 - researchgate.net
Cancer is the leading cause of death worldwide, accounting for 7.6 million deaths in 2008,
and an estimated 13.1 million deaths in 2030. 1 The burden of cancer can be reduced by …

Tumour targeting with radiometals for diagnosis and therapy

CF Ramogida, C Orvig - Chemical Communications, 2013 - hero.epa.gov
Use of radiometals in nuclear oncology is a rapidly growing field and encompasses a broad
spectrum of radiotracers for imaging via PET (positron emission tomography) or SPECT …

[引用][C] Tumour targeting with radiometals for diagnosis and therapy

CF Ramogida, C Orvig - 2013